David H. Freedman

Recent posts

VC Sky King to the Planeless: Eat My Contrails
Marc Dulude loves it when, after showing up at the far-flung offices of a company he’s thinking of buying, his eager-to-please hosts ask him how much time they’ve got to make... Read more »
Linear Air on Verge of FAA Approval for Very Light Jet Service; Backlog Already Brewing
When it comes to business travel within the Northeast, there’s nothing more satisfying than climbing into your vehicle, turning the ignition key, pulling out, and then zipping past all the traffic... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Whitepaper
How Healthy Are Your Market Access Programs?
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Archbow Consulting

Xconomy on Demand

We offer a number of ways to subscribe for free!